Two career runners out of Salem have collectively pledged to raise $30,000 on behalf of the Dana-Farber Cancer Institute as ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

Roche announced a new research hub on Friday in partnership with Harvard that it hopes will accelerate efforts in disease ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The company bearing Boston’s name has approximately 10,000 employees in Minnesota, doubling in the past 15 years. And it’s ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston ...

Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

An open letter to CEO Chris Cocks on why the toy company should relocate its headquarters to Boston from Rhode Island. It ...

Headquartered in Boston, Massachusetts, Vertex focuses on pioneering treatments for cystic fibrosis and advancing research in genetic and rare diseases, leveraging cutting-edge science to improve ...